# Study Of Intratumoral G100 In Cutaneous T Cell Lymphoma

> **NCT03742804** · PHASE2 · WITHDRAWN · sponsor: **Yale University**

## Conditions studied

- Lymphoma, T-Cell, Cutaneous

## Interventions

- **BIOLOGICAL:** Intratumoral G100

## Key facts

- **NCT ID:** NCT03742804
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-06
- **Primary completion:** 2019-12
- **Final completion:** 2022-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study sponsor sold and the new company would not support the study.
- **Last updated:** 2019-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03742804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03742804, "Study Of Intratumoral G100 In Cutaneous T Cell Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03742804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*